Marcus Wenzel

Angiolutions revolutionizes abdominal aortic aneurysm (AAA) treatment. Abdominal aortic aneurysms are threatening the lives of millions of patients around the world with no way to intercept the disease early. Angiolutions will change that. Angiolutions develops the world’s first implant fixing the root cause of deadly abdominal aortic aneurysms, intercepting the disease at an early stage. Angiolutions won an EIC Accelerator grant and is funded by the European Union. The Angiolutions® A3-Shield® System is an investigational device used exclusively for clinical investigation and not approved for commercial sale.